Get All Access for $5/mo

Mynvax Raises $4.2 Mn Series A Funding The company is developing novel recombinant vaccines for COVID-19 and human influenza and will use the proceeds to further clinical development for the same

By Prabhjeet Bhatla

Opinions expressed by Entrepreneur contributors are their own.

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

Unsplash

Mynvax, a vaccine technology startup incubated by the Society for Innovation and Development (SID) at the Indian Institute of Science, on Tuesday announced that it has signed definitive agreements to raise $4.2 million in its Series A round of financing led by Accel.

The company is developing novel recombinant vaccines for COVID-19 and human influenza and will use the proceeds to further clinical development for the same.

LetsVenture and a few early-stage angel investors also participated in this round, which received the backing of its pre-Series A investors such as 1Crowd, Kotak Investment Advisors, and other angel investors.

The company said that with the support of BIRAC, Government of India, early-stage investors, and SID, IISc, it was able to rapidly demonstrate its ability to develop novel vaccine candidates which have been rigorously tested for performance and unique attributes such as heat tolerance, that enhance access to those in need.

"Accel is excited to lead the investment in Mynvax. We strongly believe that their platform has the potential to make a huge positive change in the Global vaccine landscape for major respiratory illnesses," said Mahendran Balachandran, partner, Accel.

Dr. Nadig, the co-founder and executive director, Mynvax, said that in addition to expeditiously advancing its existing vaccine candidates, both in India and overseas, the Company would also invest in developing new vaccine modalities. He also mentioned that Mynvax would begin to build partnerships with large vaccine manufacturers to hasten the deployment of much-needed vaccines.

Incubated at the Society of Innovation and Development (SID), IISc, Mynvax has been able to leverage the scientific and technological prowess of its collaborators at IISc and other Indian and international research institutions, to build a research-driven vaccine development program.

Prabhjeet Bhatla

Former Staff

News and Trends

Noida International Airport Partners with Mahindra Logistics for Premium All-Electric Taxi Service

Passengers will have the flexibility to book rides through multiple platforms, including a dedicated mobile app, the NIA website, call centers, airport kiosks, and airline alliances. This multi-channel approach ensures 24/7 accessibility, catering to the diverse needs of travelers.

News and Trends

K12 Techno Services Secures USD 40 Mn in Funding from Kenro Capital

The Bengaluru-based firm aims to expand aggressively, with plans to open 8–12 Orchids schools annually and onboard 100–150 schools under the Eduvate umbrella each year.

News and Trends

RapidCanvas Raises USD 16 Mn to Accelerate AI Innovation in Business Operations

The new capital will fuel the expansion of its innovative offerings and global reach.

Business Ideas

63 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.

Business News

These Companies Offer the Best Work-Life Balance, According to Employees

The ranking is based on Glassdoor ratings and reviews.

Business Ideas

87 Service Business Ideas to Start Today

Get started in this growing industry, with options that range from IT consulting to childcare.